Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf007e14aceeb378ca0383da1e103b2f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
filingDate |
2018-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a665473658df7ca66c06229e8112c4b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3c4b42c90728799f1b19c60eaec2364 |
publicationDate |
2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019381069-A1 |
titleOfInvention |
3-Beta-Hydroxy-5-Alpha-Pregnan-20-One for Use in Treatment of Essential Tremor |
abstract |
The present invention provides the steroid compound 3beta-hydroxy-5alpha-pregnan-20-one for use in treatment of essential tremor, as well as methods for treating essential tremor and pharmaceutical compositions for use in treatment of essential tremor. |
priorityDate |
2017-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |